Main content area

Identification of a novel BOC-PLAG1 fusion gene in a case of lipoblastoma

Nitta, Yoshihiro, Miyachi, Mitsuru, Tomida, Akimasa, Sugimoto, Yohei, Nakagawa, Norio, Yoshida, Hideki, Ouchi, Kazutaka, Tsuchiya, Kunihiko, Iehara, Tomoko, Konishi, Eiichi, Umeda, Katsutsugu, Okamoto, Takeshi, Hosoi, Hajime
Biochemical and biophysical research communications 2019 v.512 no.1 pp. 49-52
adipocytes, adipose tissue, children, complementary DNA, exons, gene rearrangement, histology, humans, infants, messenger RNA, neoplasms, quantitative polymerase chain reaction, rapid amplification of cDNA ends, reverse transcriptase polymerase chain reaction, sequence analysis
Lipoblastoma is a rare benign adipose tissue tumor that occurs mostly in infants and children. Histological diagnosis of lipoblastoma is sometimes difficult because it closely resembles other lipomatous tumors. The detection of PLAG1 gene rearrangement is useful for the diagnosis of lipoblastoma. Four PLAG1 fusion partner genes are known in lipoblastoma: HAS2 at 8q24.1, COL1A2 at 7q22, COL3A1 at 2q32, and RAB2A at 8q12. Herein, we describe a novel fusion gene in a case of lipoblastoma of left back origin. We identified a potential PLAG1 fusion partner using 5′ rapid amplification of cDNA ends, and sequence analysis revealed the novel fusion gene, BOC-PLAG1. The BOC-PLAG1 fusion transcript consists of the first exon of the BOC gene fused to exon 2 or exon 3 of the PLAG1 gene. PLAG1 expression was found to be 35.7 ± 2.1 times higher in the tumor specimen than in human adipocytes by qRT-PCR. As a result of the translocation, the constitutively active promoter of BOC leads to PLAG1 overexpression. The identification of the BOC-PLAG1 fusion gene will lead to more accurate diagnosis of lipoblastoma.